May 16, 2003

New Non-Hormonal Low-Cost Birth Control Device Earns FDA Approval
ScrippsMemorial Hospital Chula Vista Physician Introduces New Contraceptive

Women now have an innovative new choice in birth control options. Developed by Dr. Alfred Shihata, a Scripps Health physician of Family Medicine at Scripps Memorial Hospital Chula Vista, the FemCap is a new, non-hormonal latex-free contraceptive device.

For complete article click on this site:
http://www.scripps.org/news_items/2925-new-non-hormonal-low-cost-birth-control-device-earns-fda-approval
http://www.laprensa-sandiego.org/archieve/may16-03/femcap.htm

top

New birth control option for U.S. women
Jane E. Allen, Times Staff Writer

The FemCap barrier is designed to use less spermicide and last longer. The FDA approved its use by prescription.
Women have a new contraceptive option in the FemCap, a silicone rubber device that fits snugly over the cervix and blocks the passage of sperm.

FemCap, which has been available in some European countries, is designed a bit differently from other barrier contraceptives that cover the cervix. With the cervical cap and diaphragm, spermicide gels or creams are applied inside the dome of the cap, which sits on the cervix. But FemCap is designed so that potentially irritating spermicides can be applied to a groove on the outside, with a smaller amount going inside the dome. It also features a brim that forms a seal against the vaginal walls to further protect against pregnancy.

For complete article click on this site: http://www.aegis.com/news/lt/2003/LT030415.html

POZ Magazine
U.S. Armed CERVIXES
Could an upstart diaphragm offer women condom-worthy HIV protection? Not quite yet, but the FemCap, a revamped diaphragm with a unique spermicide-delivery system that can patrol the cervix for 48 hours, is no mere baby-bouncer. Already available in the U.S., the FemCap is rarin’ to pack any of the yet-to-be-approved microbicides. The HIV-hating gels or foams—now being researched with $60 mil in funding from our fave fallopian philanthropists Bill and Melinda Gates (see “Kiss & Gel,” POZ, June 2002)—won’t hit the market till 2007 at the earliest. But POZ couldn’t wait to storm the beaches of Del Mar, California, FemCap’s corporate birthplace, to ask women whether they’d use the gizmo and the up-and-coming rebel gels.

Visit www.femcap.com for more insight on the furtive fighter.

For complete article click on this site: http://www.poz.com/articles/169_651.shtml